BronchGen is marketed as a peptide blend designed to support lung repair and respiratory function. It is not an FDA-approved medication and is typically sold in research/compounding markets.
Most BronchGen formulas contain peptides related to:
•Thymosin Beta-4 (TB-500)
•Thymosin Alpha-1
•Sometimes additional immune-modulating or tissue-repair peptides
Because it’s a blend, effects depend on the exact formulation.
⸻
What It’s Claimed to Do
Support Lung Tissue Repair
Peptides like Thymosin Beta-4 are involved in:
•Cell migration
•Tissue regeneration
•Reduced fibrosis
•Repair of epithelial tissue (including lung lining)
This is why it’s marketed for:
•Post-infection recovery
•Lung inflammation
•Tissue injury
⸻
Reduce Inflammation
Some components (especially Thymosin Alpha-1) may:
•Modulate immune response
•Reduce excessive inflammatory signaling
•Support immune balance
This is theoretical in humans unless prescribed under medical supervision.
⸻
Immune System Support
Thymosin Alpha-1 has been studied for:
•Viral infections
•Immune deficiency states
•Immune modulation
It helps regulate T-cell activity.
BronchGen is marketed to:
Support lung healing, reduce inflammation, and improve respiratory recovery.
But:
•Evidence is limited
•Effects depend on the exact peptide mix
•It should not replace medical treatment for lung disease